AJ || CEO Advice Multi-Site Health Playbook

Private equity exit pressure and secondary markets reshape liquidity

Private equity exit pressure and secondary markets reshape liquidity

Weak distributions, aging NAV, tighter lending, elevated rates, and the 2028–2029 maturity wall keep exit readiness and leverage discipline central. Broad-market commentary cites 33,853 unsold investments, holding periods near seven years, and distributions at 12% of beginning NAV versus a historical norm near 20%; these are not healthcare-specific realized performance. T. Rowe Price’s 2027 outlook favors selective structured capital, secondaries, and infrastructure, not evidence of healthcare deal returns.

Sources (6)
Updated Nov 18, 2026